Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action

Project Information

EUROFANCOLEN

Grant agreement ID: 305421

Project closed

Start date 1 January 2013

End date 31 December 2018

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 014 945,20

EU contribution € 5 380 169,75

Coordinated by

CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .